THIS IS AN EXEPTIONAL CANCER SURVIVOR

Long-Term Cancer Survivors are all patients who survive more than 5 years after diagnosis of highly lethal Cancers. Cure51 unlocks these Outliers' secrets to eradicate Cancer before 2035.

THIS IS AN EXEPTIONAL CANCER SURVIVOR

Long-Term Cancer Survivors are all patients who survive more than 5 years after diagnosis of highly lethal Cancers. Cure51 unlocks these Outliers' secrets to eradicate Cancer before 2035.

SCROLL TO EXPLORE

UNTIL ALL SURVIVE.

A world where exceptional Cancer survivors become the blueprint for curing everyone!

Because miracles should happen for all.

Co-founded with Leading centers

OUR MISSION

`WE IDENTIFY AND COLLECT UNIQUE DATA FROM THOUSANDS OF long-term cancer SURVIVORS.`

Oncology players usually look at the biology  of the 99% of the patients who die from the most lethal Cancers.

At Cure51, we are focusing on exceptional Cancer survivors from across all continents, to build a unique clinical and multi-omics database and contribute to Cancer eradication.

At Cure 51, we are focusing on Cancer survivors from across all continents to build a unique clinical and multi-omics database and contribute to Cancer eradication.

`WE IDENTIFY AND COLLECT UNIQUE DATA FROM THOUSANDS OF long-term cancer SURVIVORS.`

Oncology players usually look at the biology  of the 99% of the patients who die from the most lethal Cancers.

At Cure51, we are focusing on exceptional Cancer survivors from across all continents, to build a unique clinical and multi-omics database and contribute to Cancer eradication.

Cure51 focuses on extraordinary patients.

the Exception

that proves

the rule.

WE ARE A TECH-BIO COMPANY

SURVIVORS DATA ARE OUR COMPASS TOWARDS SUCCESS OF NOVEL ONCOLOGY DRUG PROGRAMS.

We have set up one of the largest Cancer network in history, covering every continent, and have successfully established collaboration with the world's leading Cancer centers.

Our computational biology team works with our scientific partners to discover multimodal signatures and create a library of robust targets contributing to the design of best-in-class drugs.

We develop precision medicine tools in order to deliver actionable insights to discover novel therapeutics.

WE ARE A TECH- BIO COMPANY

SURVIVORS DATA ARE OUR COMPASS TOWARDS SUCCESS OF NOVEL ONCOLOGY DRUG PROGRAMS.

We have built one of the largest Cancer network in history, across all continents and managed to bring to our captable 3 leading Cancer centers in the world.

Our computational biology team works with our scientific partners to discover multimodal signatures and create a library of robust targets contributing to the design of best-in-class drugs.

We develop precision medicine tools in order to deliver actionable insights to discover novel therapeutics.